Register for our S/EIS Fund

o2h discovery is pleased to announce a 10 FTE Synthetic Chemistry collaboration with Heptares. Giles Brown, Director of Medicinal Chemistry: “Heptares is pleased to expand its discovery chemistry collaboration with o2h discovery. The group has demonstrated good value for Heptares with a focus on fast turn-around, transparent communications and speed of delivery.” Sunil Shah, CEO: “We are very happy to support this incredible group of scientists at Heptares.